Company profile: Mobidiag
1.1 - Company Overview
Company description
- Provider of molecular diagnostic solutions for the detection of infectious diseases, including gastrointestinal infections, antimicrobial resistance management, healthcare-associated infections (HAIs), respiratory infections and sepsis, based on well-established qPCR and microarray technologies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mobidiag
Bellwether Bio
HQ: United States
Website
- Description: Provider of novel cell-free DNA-based diagnostic technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bellwether Bio company profile →
Advesya
HQ: France
Website
- Description: Provider of therapies for difficult-to-treat cancers, focusing on immuno-oncology and hematological malignancies, leveraging biochemistry and molecular and cellular biology expertise. Offers ADV-101, a topoisomerase I inhibitor antibody-drug conjugate targeting IL-1RAP for esophageal cancer, delivering cytotoxic agents directly to cancer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advesya company profile →
Favrille
HQ: United States
Website
- Description: Provider of targeted immunotherapies, focused on research, development and commercialization for the treatment of cancer and other diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Favrille company profile →
SpringWorks Therapeutics
HQ: United States
Website
- Description: Provider of targeted oncology therapies for cancer and rare diseases, focused on innovative treatments for unmet needs. Portfolio includes nirogacestat, an oral gamma secretase inhibitor for desmoid tumors and in evaluation for ovarian granulosa cell tumors and multiple myeloma; mirdametinib, a MEK inhibitor for NF1-associated plexiform neurofibromas; brimarafenib (BGB-3245), a RAF fusion/dimer inhibitor; and SW-682, a TEAD inhibitor.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SpringWorks Therapeutics company profile →
Pyxis Oncology
HQ: United States
Website
- Description: Provider of antibody therapeutics intended to promote the body's immune response to cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pyxis Oncology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mobidiag
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mobidiag
2.2 - Growth funds investing in similar companies to Mobidiag
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mobidiag
4.2 - Public trading comparable groups for Mobidiag
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →